IHH Healthcare’s 1QFY2021 ended March results were in line with UOB Kay Hian’s estimates, with analyst Philip Wong viewing it as a “strong start to the year”.
IHH Healthcare
Price target:
UOB Kay Hian “buy” RM5.70
Strong start to FY21 but tightened measures pose headwinds

